This revealed a reduction in the fractional labeling of citrate and AKG ( Figure 2 I), although this did not reach statistical significance for citrate.
← all excerpts
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.
1
—
—